| 82.1 -1.27 (-1.52%) | 06-17 16:00 | |||||||||||||
|
|
| Short term |   |
|||
| Mid term |  |
|||
| Targets | 6-month : | 100.38 | 1-year : | 117.25 |
| Resists | First : | 85.94 | Second : | 100.38 |
| Pivot price | 82.57  |
|||
| Supports | First : | 79.62 | Second : | 75.7 |
| MAs | MA(5) : | 83.55 |
MA(20) : | 81.84 |
| MA(100) : | 83.79 |
MA(250) : | 91.48 |
|
| MACD | MACD : | 1 |
Signal : | 1 |
| %K %D | K(14,3) : | 62.9 |
D(3) : | 70.8 |
| RSI | RSI(14): 51.3 |
|||
| 52-week | High : | 105.47 | Low : | 66.66 |
Price has closed below its short-term moving average. Short-term moving average is currently above mid-term; and below long-term moving average. From the relationship between price and moving averages: This stock is NEUTRAL in short-term; and NEUTRAL in mid-long term.[ XBI ] has closed above bottom band by 43.7%. Bollinger Bands are 17.4% narrower than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.
| If tomorrow: | Open lower | Open higher |
| High: | 84.1 - 84.9 | 84.9 - 85.39 |
| Low: | 80.14 - 81.21 | 81.21 - 81.85 |
| Close: | 80.89 - 82.61 | 82.61 - 83.65 |
In seeking to track the performance of the S&P Biotechnology Select Industry Index (the "index"), the fund employs a sampling strategy. It generally invests substantially all, but at least 80%, of its total assets in the securities comprising the index. The index represents the biotechnology segment of the S&P Total Market Index ("S&P TMI").
Thu, 05 Jun 2025
7 Top-Performing Equal-Weight ETFs to Buy Now - US News Money
Mon, 26 May 2025
SPY Stock Price Today: SPDR S&P 500 ETF Trust Sees Mixed Performance - Markets.com
Thu, 22 May 2025
Best SPDR ETFs to Buy and Hold - Kiplinger
Mon, 21 Apr 2025
SPDR S&P Dividend ETF (SDY) - VettaFi | ETF of the Week - Podcasts - Advisor Perspectives
Wed, 16 Apr 2025
Live: SPDR S&P 500 ETF Trust (SPY) Falls From Nvidia, Trade Pressure - MSN
Wed, 16 Apr 2025
SPDR S&P 500 ETF Trust (SPY) Drops Heavily on Powell Comments, Down 150bps today - StreetInsider
| Price to Book Value: P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly. |
Neutral |
| Price to Earnings: PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS). |
Neutral |
| Discounted cash flow: DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows. |
Neutral |
| Return on Assets: ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit. |
Neutral |
| Return on Equity: ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency. |
Neutral |
| Debt to Equity: evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn. |
Neutral |
|
Exchange:
AMEX
|
|
|
Sector:
Financial Services
|
|
|
Industry:
Asset Management
|
|
| Shares Out | 0 (M) |
| Shares Float | 0 (M) |
| Held by Insiders | 0 (%) |
| Held by Institutions | 0 (%) |
| Shares Short | 0 (K) |
| Shares Short P.Month | 0 (K) |
| EPS | 0 |
| EPS Est Next Qtrly | 0 |
| EPS Est This Year | 0 |
| EPS Est Next Year | 0 |
| Book Value (p.s.) | 0 |
| Profit Margin | 0 % |
| Operating Margin | 0 % |
| Return on Assets (ttm) | 0 % |
| Return on Equity (ttm) | 0 % |
| Qtrly Rev. Growth | 0 % |
| Gross Profit (p.s.) | 0 |
| Sales Per Share | 0 |
| EBITDA (p.s.) | 0 |
| Qtrly Earnings Growth | 0 % |
| Operating Cash Flow | 0 (M) |
| Levered Free Cash Flow | 0 (M) |
| PE Ratio | 0 |
| PEG Ratio | 0 |
| Price to Book value | 0 |
| Price to Sales | 0 |
| Price to Cash Flow | 0 |
| Dividend | 0 |
| Forward Dividend | 0 |
| Dividend Yield | 0% |
| Dividend Pay Date | Invalid DateTime. |
| Ex-Dividend Date | Invalid DateTime. |
|
|
|
|
|
|
|
|
|